Nursing · Independent exam preparation
Certified Nephrology Nurse (CNN) Examination Study Guide
Practise CKD classification, acute kidney rescue, dialysis troubleshooting and transplant surveillance through 60 focused concepts and 20 CNN learning questions.
By CertMedbry · Updated 27 October 2026
Practise distinguishing chronic kidney disease from acute injury, recognizing urgent treatment needs, troubleshooting home therapies, and protecting a transplanted kidney. This selective guide contains 60 concepts distributed across CNN's five content domains, followed by independent learning questions and recall cards. The official NNCC specifications and blueprint define the full examination scope; these clinical topics illustrate that scope without replacing it.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which credential and jurisdiction does this guide cover?
The credential is Certified Nephrology Nurse (CNN), awarded by the Nephrology Nursing Certification Commission. The current eligibility page requires a full, unrestricted registered nurse license in the United States or its territories. CNN addresses multiple nephrology practice areas. CNN-NP is a separate nurse practitioner credential, and CDN has a different, primarily hemodialysis-focused scope.
CNN — Nephrology Nursing Certification Commission · Attention All Current CDN and CNN Certificants — January 19, 2026
How many questions are on the examination, and how long is allowed?
The CNN examination contains 150 questions with a three-hour time limit. The official blueprint distributes those 150 items across the five content domains.
CNN — Nephrology Nursing Certification Commission · New Test Blueprint: Distribution of 150 Items in the Certified Nephrology Nurse Examination
What delivery method and question styles does NNCC describe?
NNCC provides computer-based testing information and examination-site links. Its answering guidance describes four answer choices, and its official practice test uses multiple-choice questions. The questions in this guide are independent four-option, single-best-answer drills.
Which blueprint applies to this guide?
The CNN Test Specifications were revised in April 2026 and became effective September 1, 2026. The currently linked New Test Blueprint agrees with those content weights but prints no separate effective date. These specifications govern this guide.
Certified Nephrology Nurse Examination (CNN): Weights for Blueprint Categories · New Test Blueprint: Distribution of 150 Items in the Certified Nephrology Nurse Examination
How are the five content domains weighted?
The official weights are Concepts of Kidney Disease Across the Life Span 30%, Acute Inpatient Therapies 25%, Peritoneal Dialysis 20%, Home Hemodialysis 15%, and Transplant 10%. This guide allocates its 60 concepts as 18, 15, 12, 9, and 6 respectively. Both the questions and flashcards use allocations of 6, 5, 4, 3, and 2.
Certified Nephrology Nurse Examination (CNN): Weights for Blueprint Categories · New Test Blueprint: Distribution of 150 Items in the Certified Nephrology Nurse Examination
Which abilities are assessed across the content domains?
The specifications weight pathology and complications at 20%; interventions at 21%; physiological and technical principles at 11%; teaching at 15%; medication administration at 12%; infection control at 8%; and collaboration, psychological and cultural considerations, staff development, and quality improvement at 13%. Apply these abilities across modalities. This small learning set does not reproduce every cell of the official content-by-objective matrix.
Certified Nephrology Nurse Examination (CNN): Weights for Blueprint Categories · New Test Blueprint: Distribution of 150 Items in the Certified Nephrology Nurse Examination
What passing standard does NNCC publish?
The current CNN page states that a standard score of 95 is required and describes this as answering 70% of test questions correctly. This guide does not convert practice performance into an official score or predict examination success.
What eligibility changes should candidates distinguish from examination content?
NNCC's January 2026 announcement describes removal of the BSN requirement. The current CNN page lists an unrestricted US or territorial RN license, at least 2,500 hours in specified nephrology areas within the preceding two years, and 30 approved nephrology continuing-education contact hours within that period. These are application requirements, not additional clinical blueprint domains.
CNN — Nephrology Nursing Certification Commission · Attention All Current CDN and CNN Certificants — January 19, 2026
How do clinical guideline dates relate to the examination blueprint?
The NNCC outline establishes examination scope; clinical guidelines support the explanations. This guide uses established AKI criteria from KDIGO's published 2012 guideline. As of October 27, 2026, KDIGO describes the 2026 AKI/AKD update as awaiting final publication after public review. Draft recommendations are not final clinical guidance.
Acute Kidney Injury and Acute Kidney Disease — KDIGO · KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury · Certified Nephrology Nurse Examination (CNN): Weights for Blueprint Categories
This guide covers NNCC's Certified Nephrology Nurse examination for registered nurses, using the specifications effective September 1, 2026. CNN-NP and Certified Dialysis Nurse (CDN) are separate credentials. These independently authored educational materials do not imply NNCC endorsement.
Outline used: CNN Test Specifications revised April 2026, effective September 1, 2026, with the currently linked New Test Blueprint; verified for October 11, 2026. The workbook label Certified Nephrology Nurse maps directly to NNCC's CNN examination. Assigned slug preserved.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Concepts of Kidney Disease Across the Life Span30%
1.When does an abnormal kidney result establish CKD?
Chronic kidney disease requires an abnormality of kidney structure or function present for at least three months, with implications for health. A reduced estimated glomerular filtration rate or elevated urine albumin can identify a problem, but one abnormal result does not establish chronicity. Previous laboratory results, imaging, pathology, and repeat testing help distinguish persistent disease from acute injury. An acute deterioration can also occur in someone with established CKD.
Apply it
A patient has an eGFR of 42 during gastroenteritis, with no previous results available. Recognize reduced kidney function, assess for acute causes, and seek earlier records before labeling the finding as established CKD.
Common pitfall: Calling every isolated low eGFR CKD overlooks reversible acute injury. Conversely, a previous CKD diagnosis does not explain away a new acute decline.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
2.How does CGA classification describe CKD?
CKD classification combines cause, GFR category, and albuminuria category, abbreviated CGA. G3a means eGFR 45–59, whereas G3b means 30–44 mL/min/1.73 m². Albuminuria categories are A1 below 30, A2 30–300, and A3 above 300 mg/g urine albumin-to-creatinine ratio. Recording both dimensions prevents a moderately reduced eGFR from obscuring substantial albumin leakage. Cause remains important because similar filtration values can arise from different disease processes and treatment needs.
Apply it
An adult with established diabetic kidney disease has eGFR 52 and urine ACR 180 mg/g on repeat testing. Describe the classification as diabetic CKD G3a A2 rather than reporting only stage 3.
Common pitfall: G3a does not mean eGFR 30–44. Albuminuria category cannot be inferred from serum creatinine, and a numerical stage does not identify the cause.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
3.How should an elevated urine ACR be confirmed?
Urine albumin-to-creatinine ratio estimates albumin loss while accounting partly for urine concentration. A first-morning midstream specimen is preferred for confirmation when feasible. Exercise, infection, menstruation, and other transient influences can increase albumin measurements, so context matters. An abnormal random sample should prompt confirmation rather than an automatic assumption of persistent disease. Use the numerical ACR and its units; urine albumin concentration alone is more vulnerable to dilution effects.
Apply it
A random ACR is elevated after a strenuous race. The patient has no previous kidney findings. Arrange a first-morning repeat when the transient influence has resolved and evaluate persistence before assigning an albuminuria category.
Common pitfall: A concentrated urine sample can mislead when albumin concentration is interpreted alone. One elevated ACR also does not establish the three-month chronicity requirement.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
4.What establishes CKD when eGFR is at least 60?
An eGFR in G1 or G2 does not by itself establish CKD. Persistent markers of kidney damage, such as albuminuria, characteristic urine sediment abnormalities, or structural disease, can establish CKD despite preserved filtration. The key distinction is between a filtration category and a disease diagnosis. Duration still matters: qualifying abnormalities must generally persist for at least three months. A normal-looking eGFR therefore neither proves nor excludes kidney disease.
Apply it
Two patients have eGFR 78. One has persistent ACR 420 mg/g over six months; the other has no damage markers. The first has evidence supporting CKD, while the second value alone does not establish it.
Common pitfall: Treating G2 as a diagnosis overlabels healthy people. Treating eGFR above 60 as proof of healthy kidneys misses persistent albuminuric or structural disease.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
5.Why can creatinine-based eGFR mislead in low muscle mass?
Creatinine production depends partly on muscle mass, so a low serum creatinine can reflect reduced production rather than strong filtration. Creatinine-based eGFR may overestimate kidney function in a person with substantial muscle wasting. When accuracy affects an important decision, combined creatinine–cystatin C estimation or measured GFR may improve assessment. Interpret the estimate alongside body composition and clinical context rather than assuming that the laboratory number is a direct measurement.
Apply it
An older adult with marked muscle wasting has a reassuring creatinine-based eGFR before a medication decision requiring accurate kidney assessment. Flag the mismatch and discuss confirmatory assessment rather than accepting the estimate without context.
Common pitfall: A low creatinine is not always reassuring. Cystatin C also has non-GFR influences, so no estimate should be interpreted without the clinical picture.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
6.Why assess albuminuria and eGFR together?
Albuminuria and eGFR provide complementary prognostic information. eGFR describes filtration, whereas albuminuria indicates abnormal protein leakage and helps identify kidney and cardiovascular risk. Two people with the same eGFR can have substantially different risk profiles when their albuminuria differs. Follow-up intensity and protective care should therefore consider both measurements, their trends, and the underlying cause. A stable filtration estimate does not make a rising ACR clinically irrelevant or remove the need for review.
Apply it
Two patients have persistent eGFR 50. One has ACR 12 mg/g and the other 650 mg/g. Explain why the second patient warrants a different risk discussion despite their matching filtration category.
Common pitfall: Using eGFR alone hides albuminuria-related risk. A single risk marker also cannot replace assessment of cause, comorbidities, trajectory, and the patient's overall condition.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
7.Why does CKD cause anemia?
Healthy kidneys produce erythropoietin, which signals bone marrow to make red blood cells. Kidney disease can reduce that signal, contributing to anemia and reduced oxygen delivery. CKD-associated anemia is often multifactorial: iron deficiency, inflammation, blood loss, and other nutritional or hematologic problems may coexist. Fatigue and exertional breathlessness are relevant clues, but symptoms alone cannot establish the cause. Evaluate the blood count and contributing conditions before attributing every low hemoglobin to erythropoietin deficiency.
Apply it
A person with CKD reports new fatigue and has a falling hemoglobin. Explain the possible kidney-related mechanism while arranging evaluation for iron deficiency, bleeding, and other contributors instead of assuming one cause.
Common pitfall: Reduced erythropoietin is an important mechanism, not a complete diagnosis. Automatically escalating anemia treatment can miss bleeding, iron restriction, or another treatable condition.
Anemia in Chronic Kidney Disease — NIDDK · KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease
8.How do ferritin and TSAT distinguish iron problems?
Ferritin helps assess iron stores, while transferrin saturation estimates circulating iron available for erythropoiesis. Inflammation can raise ferritin and restrict iron release, producing low TSAT despite apparently adequate stored iron. This pattern differs from straightforward depletion of iron stores. Interpret both measurements with hemoglobin trends, inflammatory illness, and treatment history. A high ferritin therefore does not reliably exclude restricted iron availability, and it should not be treated as an isolated instruction to give or withhold iron.
Apply it
A patient with CKD and a recent inflammatory illness has anemia, low TSAT, and elevated ferritin. Recognize possible restricted iron availability and request integrated assessment rather than documenting that iron status is normal.
Common pitfall: Ferritin is an acute-phase reactant as well as an iron marker. Neither ferritin nor TSAT alone establishes a universal treatment decision for every patient.
KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease
9.Which findings suggest anemia needs a broader evaluation?
Anemia assessment should examine whether the pattern fits reduced red-cell production alone or suggests another process. A rapid hemoglobin fall, visible bleeding, abnormal red-cell indices, or inadequate response to treatment warrants investigation for additional causes. Initial evaluation commonly includes a blood count, reticulocytes, ferritin, and TSAT, with further testing guided by findings. Identifying blood loss or nutritional deficiency matters because treating the kidney-related component alone will not correct a continuing competing cause.
Apply it
A stable CKD patient develops a rapid hemoglobin decline and reports dark stools. Escalate assessment for possible gastrointestinal blood loss rather than treating the change as expected progression of kidney-related anemia.
Common pitfall: A known CKD diagnosis can create diagnostic anchoring. A sudden change or atypical blood count should reopen the differential rather than trigger automatic treatment escalation.
KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease
10.How does CKD disrupt mineral and bone regulation?
Declining kidney function impairs phosphate handling and reduces activation of vitamin D. These changes disturb calcium balance and stimulate compensatory parathyroid hormone responses, contributing to abnormal bone turnover. Mineral imbalance can also affect blood vessels and other tissues, so CKD mineral and bone disorder extends beyond skeletal pain. Interpret calcium, phosphate, and parathyroid hormone patterns together over time. An isolated normal calcium value does not exclude a developing disorder or establish that bone metabolism is normal.
Apply it
A patient asks why bone-related laboratory tests are ordered despite having no fractures. Explain that hormonal and mineral disturbances may develop before symptoms and that trends help guide coordinated dietary and medication management.
Common pitfall: CKD mineral and bone disorder is not simply dietary calcium deficiency. Taking extra calcium without reviewing the overall mineral pattern can create additional problems.
11.Why are phosphate binders coordinated with food?
Phosphate binders work within the gastrointestinal tract by binding phosphate from food and reducing its absorption. Their effect therefore depends on contact with dietary phosphate, making meal-related administration important. They do not remove phosphate already circulating in the blood and do not replace dialysis or an individualized nutrition plan. Review the prescribed product, meal pattern, and administration instructions when phosphate remains elevated. Missed doses with meals may explain poor control despite reported daily use.
Apply it
A patient takes every prescribed binder tablet at bedtime, several hours after dinner. Ask the patient to demonstrate the usual schedule, explain the food-binding mechanism, and reconcile timing with the prescribed meal instructions.
Common pitfall: Counting tablets taken each day can miss ineffective timing. Product-specific directions and interactions still matter; binders should not be treated as interchangeable supplements.
12.Why is growth an important pediatric CKD outcome?
Children with CKD may develop impaired growth because kidney disease affects nutrition, hormones, and mineral and bone metabolism during development. Growth assessment therefore requires serial height and weight measurements interpreted against the child's trajectory, rather than adult laboratory targets alone. Poor growth can be a clinically meaningful complication even when the child reports little discomfort. Care planning should integrate pediatric nephrology, nutrition, family routines, and management of the underlying metabolic disturbances.
Apply it
A child with CKD has crossed downward through height percentiles while reporting no bone pain. Bring the growth trend to the pediatric kidney team and review nutrition and mineral management with the family.
Common pitfall: Absence of bone pain does not exclude important pediatric consequences. Adult-focused teaching that overlooks development can miss growth impairment and family-specific treatment barriers.
13.Why are NSAIDs particularly risky during dehydration?
During reduced circulating volume, kidney perfusion becomes more dependent on protective local mechanisms, including prostaglandin-mediated blood flow. NSAIDs interfere with these mechanisms and can precipitate acute kidney injury, especially in people with CKD or other risk factors. Vomiting, diarrhea, poor intake, and low blood pressure are important contextual clues. Medication teaching should include over-the-counter pain and cold products because patients may not recognize them as medicines that can affect kidney function.
Apply it
A patient with CKD develops vomiting and plans to take ibuprofen for body aches. Identify dehydration plus NSAID exposure as a kidney risk and help obtain an appropriate medication and illness-management plan.
Common pitfall: Over-the-counter availability does not mean kidney safety. A medicine tolerated during stable hydration may become hazardous during acute illness or reduced circulating volume.
14.How does medication reconciliation prevent kidney-related harm?
Medication reconciliation compares what a patient actually takes with the intended regimen, including prescriptions, nonprescription products, vitamins, and supplements. Kidney disease can change drug elimination, while acute illness can change the safety of a previously stable regimen. Ask about purpose, dose, timing, duplicate ingredients, and recent changes. An accurate list allows the care team to identify nephrotoxic exposure, interactions, and medicines needing reassessment when kidney function or hydration changes.
Apply it
A patient brings separate medication lists from three clinicians and an unlisted cold remedy. Compare the actual containers with the lists, identify duplicate ingredients, and communicate discrepancies before updating the shared regimen.
Common pitfall: Copying the electronic list is not reconciliation. Patients may use supplements, borrowed medicines, or combination products that are absent from the recorded prescription history.
15.How should nutrition advice respond to individual CKD findings?
Kidney nutrition advice should reflect disease severity, laboratory findings, medications, nutritional status, and treatment modality. A blanket prohibition on broad food groups can reduce intake without addressing the patient's actual problem. Potassium, phosphate, protein, and energy needs are not identical for all people with CKD. A kidney dietitian can translate clinical goals into achievable food choices while protecting adequate nutrition. Review changes in appetite, weight, and muscle function alongside biochemical results.
Apply it
A patient has stopped fruit, vegetables, dairy, and most protein after reading a generic kidney diet. With falling weight and poor intake, arrange individualized dietitian review rather than adding further restrictions automatically.
Common pitfall: More restriction is not always safer. Laboratory abnormalities and nutritional vulnerability must be considered together, particularly when advice threatens adequate energy or protein intake.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease · Anemia in Chronic Kidney Disease — NIDDK
16.How does teach-back reveal a misunderstanding?
Teach-back asks the learner to explain a plan in their own words so the clinician can assess how clearly it was taught. It is more informative than asking whether the patient understands. For a physical task, use return demonstration. Present a small amount of information, invite explanation without blame, correct gaps, and check again. Frame the exercise as a test of the explanation rather than the patient's intelligence or willingness to cooperate.
Apply it
After teaching binder timing, ask the patient to describe how tomorrow's meals and tablets will fit together. If the schedule is incorrect, explain it differently and repeat teach-back before ending the visit.
Common pitfall: A nod or a yes response does not establish understanding. Repeating the same wording louder may preserve the misunderstanding rather than resolve it.
17.How should treatment planning incorporate patient priorities?
Shared planning combines clinical suitability with the person's goals, daily responsibilities, resources, and preferences. Kidney replacement options and conservative kidney management have different burdens and benefits, so education should support an informed decision rather than assume one universal best pathway. Interdisciplinary input can address nutrition, home circumstances, psychological distress, and practical barriers. Revisit the discussion as health or priorities change, and check that the patient understands what each realistic option would involve.
Apply it
A patient values staying employed but feels overwhelmed by home treatment responsibilities. Coordinate discussion with nursing, nephrology, and social work to compare feasible schedules and support needs before assuming that home therapy fits.
Common pitfall: Modality education becomes coercive when convenience for the service replaces the patient's goals. Preference also requires an accurate understanding of practical demands and alternatives.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
18.Why assess frailty and function alongside eGFR?
People with similar kidney measurements may differ greatly in mobility, cognition, nutrition, symptom burden, and ability to manage treatment. Frailty and functional assessment help identify whether an apparently reasonable plan creates excessive burden or needs additional support. In older adults, preserve attention to falls, medication complexity, and patient goals rather than treating chronological age as the decision rule. These assessments complement kidney risk estimates and make care planning more individualized and realistic.
Apply it
Two older adults have the same eGFR, but one independently manages medications while the other has falls and cognitive difficulty. Assess support and treatment burden separately instead of offering identical self-management plans.
Common pitfall: Age alone neither determines treatment suitability nor measures frailty. A laboratory-centered plan can overlook the functional barriers that actually determine safe daily care.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
Acute Inpatient Therapies25%
19.What changes meet established AKI diagnostic criteria?
Established KDIGO criteria identify AKI by a serum creatinine increase of at least 0.3 mg/dL within 48 hours, an increase to at least 1.5 times baseline within seven days, or urine output below 0.5 mL/kg/hour for six hours. Either creatinine or urine output can establish the diagnosis. Compare measurements with a credible baseline and a defined time interval. A creatinine that remains within the laboratory reference range can still represent AKI.
Apply it
A patient's creatinine rises from 0.8 to 1.2 mg/dL within 36 hours. Recognize that the absolute increase meets an AKI criterion, even though the latest value may appear only mildly elevated.
Common pitfall: Waiting for creatinine to exceed the laboratory range delays recognition. A single value without baseline or timing cannot establish the size and speed of change.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
20.How do urine output and creatinine determine AKI stage?
AKI staging uses the more severe stage reached by creatinine or urine-output criteria. For urine output, below 0.5 mL/kg/hour for at least 12 hours reaches stage 2; below 0.3 for at least 24 hours or anuria for at least 12 hours reaches stage 3. Accurate body weight, volume, and elapsed time are essential. Urine-output criteria may identify severe injury before creatinine has risen enough to reflect it.
Apply it
A 70-kg adult produces 280 mL over 14 hours, averaging about 0.29 mL/kg/hour. This meets stage 2 urine-output criteria, but the duration is insufficient for the stage 3 low-output criterion.
Common pitfall: Do not assign stage from a single hourly volume or from the lower of two qualifying stages. Duration and the worst qualifying criterion matter.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
21.How should perfusion and congestion guide AKI assessment?
Reduced kidney perfusion can cause or worsen AKI, but oliguria does not prove that a patient needs more fluid. Assess blood pressure, recent losses, intake, examination findings, respiratory status, and cumulative balance to distinguish depletion from congestion. Fluid administration can help selected volume-depleted patients while worsening pulmonary edema in an overloaded patient. Reassess the response to any intervention rather than assuming that increased input will necessarily restore urine production or improve filtration.
Apply it
An oliguric inpatient has rising oxygen needs, crackles, and a strongly positive fluid balance. Escalate assessment of congestion and perfusion rather than giving an automatic fluid bolus solely because urine output is low.
Common pitfall: Oliguria is a finding, not a prescription for fluid. Hypotension and edema can coexist, requiring integrated assessment rather than reliance on one sign.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
22.When should urinary obstruction be considered in AKI?
Postrenal obstruction is a potentially reversible cause of AKI. Abruptly reduced urine output should prompt assessment of the drainage system and clinical risks for obstruction, alongside other causes. A kinked catheter or retention differs from intrinsic loss of filtration, and upper-tract obstruction may require imaging. Identifying a mechanical problem matters because fluids or diuretics do not relieve the underlying blockage. Evaluate promptly while maintaining attention to the patient's overall stability and electrolyte status.
Apply it
A catheterized patient suddenly stops draining urine after repositioning. Inspect the tubing and drainage setup and assess for retention while escalating unresolved anuria, rather than assuming that kidney function has abruptly ceased.
Common pitfall: A urinary catheter does not exclude obstruction. Correcting an external drainage problem also does not eliminate the need to reassess persistent AKI or electrolyte abnormalities.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
23.Which complications make kidney replacement therapy urgent?
Kidney replacement therapy is urgent when life-threatening fluid, electrolyte, or acid-base disturbances require extracorporeal correction. Examples include refractory hyperkalemia, severe pulmonary edema, and severe acidosis that cannot be adequately controlled otherwise. The decision depends on the clinical context, trend, and complications rather than a single creatinine or urea threshold. A patient with modest azotemia may need urgent treatment, while a higher isolated creatinine does not itself establish the same urgency.
Apply it
A patient with AKI has worsening hypoxemia from pulmonary edema despite medical treatment. Recognize a potential urgent kidney replacement indication and prepare for coordinated escalation without waiting for a predetermined creatinine value.
Common pitfall: A numerical creatinine trigger oversimplifies initiation. Conversely, temporary improvement in one laboratory value does not resolve an ongoing life-threatening fluid or acid-base problem.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
24.Why may CRRT suit a hemodynamically unstable patient?
Continuous kidney replacement therapy distributes solute and fluid removal over a prolonged period. This can reduce the abrupt physiological shifts associated with intermittent treatment and supports careful balance management in hemodynamically unstable patients. KDIGO suggests CRRT rather than standard intermittent therapy for such patients, while recognizing that modalities complement one another. Selection also depends on treatment goals, resources, and clinical circumstances. Continuous treatment does not eliminate hypotension, access problems, or the need for close reassessment.
Apply it
A patient on vasopressors requires ongoing fluid removal and poorly tolerates rapid changes. Explain why the team may select CRRT and monitor whether the prescribed removal remains compatible with perfusion during treatment.
Common pitfall: CRRT is not automatically superior for every AKI patient. Its gradual delivery still requires individualized fluid goals and attention to interruptions and hemodynamic response.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
25.How do diffusion and convection remove solutes?
Diffusion moves solutes across a semipermeable membrane down a concentration gradient, as in hemodialysis. Convection carries dissolved solutes with water moving across the membrane, as in hemofiltration. Hemodiafiltration combines these processes. This distinction helps explain why dialysate and replacement-fluid pathways have different functions in continuous therapies. Solute clearance and net patient fluid removal are related treatment features but are not interchangeable quantities; the circuit can process substantial fluid without removing that volume from the patient.
Apply it
A learner sees both dialysate and replacement-fluid bags on a continuous therapy circuit. Ask which pathway primarily supports diffusion and which replaces fluid associated with convective clearance before discussing the separate net-removal goal.
Common pitfall: Calling every bag a dialysate bag obscures the treatment mechanism. Large effluent production also does not mean the patient loses that entire volume.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
26.How is cumulative fluid balance calculated?
Measured fluid balance is recorded intake minus recorded output over a defined interval. Include relevant infusions, nutrition, medications, urine, drains, and treatment-related net removal without double-counting. A positive balance means recorded input exceeded recorded output. It is an accounting estimate, not a direct measurement of intravascular volume, because unmeasured losses and documentation errors remain possible. Compare balance with weight trends, physical findings, and respiratory status before interpreting its clinical meaning.
Apply it
Over 24 hours, recorded intake is 2,400 mL, urine is 450 mL, drains total 150 mL, and net extracorporeal removal is 1,200 mL. The measured balance is positive 600 mL for that interval.
Common pitfall: Do not add net treatment removal twice if it is already included in recorded output. A positive balance alone does not reveal where fluid is distributed.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
27.How does CRRT effluent differ from net patient fluid removal?
CRRT effluent includes fluid leaving the circuit for clearance, including spent dialysate and ultrafiltrate depending on the modality. Replacement-fluid and dialysate flows mean effluent volume is not equivalent to net fluid removed from the patient. Patient balance requires the machine's net-removal information plus other intake and output. Understanding this separation prevents dramatic accounting errors and helps distinguish a clearance prescription from the intended rate of patient fluid loss.
Apply it
A CRRT machine reports 2,000 mL/hour effluent but a net patient removal setting of 75 mL/hour. Use the net-removal value for patient fluid accounting, then integrate other intake, output, and actual treatment time.
Common pitfall: Subtracting total effluent from patient intake greatly overstates fluid loss. Also distinguish the ordered net-removal setting from the volume actually achieved during interruptions.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
28.What does intravenous calcium accomplish in severe hyperkalemia?
Intravenous calcium counteracts the cardiac membrane effects of hyperkalemia when indicated by the emergency assessment, particularly toxic ECG changes. It acts rapidly to protect electrical stability but does not lower the potassium concentration or remove potassium from the body. Other interventions must shift potassium into cells or eliminate it. Continue cardiac and biochemical reassessment because the protective effect is temporary and the underlying potassium burden may remain dangerous after the ECG improves.
Apply it
A patient with severe hyperkalemia and a widened QRS receives prescribed intravenous calcium. Explain that cardiac protection is being provided while the team also arranges potassium-shifting and elimination measures with continued monitoring.
Common pitfall: An improved ECG after calcium does not mean potassium has normalized. Calcium's protective role must not be mistaken for definitive potassium removal or completed treatment.
UKKA Clinical Practice Guideline: Management of Hyperkalaemia in Adults — July 2026
29.Why monitor glucose after insulin treatment for hyperkalemia?
Insulin lowers extracellular potassium by promoting movement into cells, but it also lowers blood glucose. Hypoglycemia can develop after an initially normal reading, and kidney impairment can increase vulnerability to prolonged effects. As a concrete clinical example, UKKA recommends glucose checks at 0, 30, 60, 90, 120, 180, 240, 300 and 360 minutes after insulin-glucose treatment, with time 0 providing the baseline. Selected high-risk patients, including those receiving repeated insulin-glucose treatment, need extended monitoring. This is UKKA clinical guidance, not an NNCC examination requirement; institution-specific implementation governs prescribed glucose support, checks, and responses. Potassium also requires reassessment because shifting does not remove excess potassium.
Apply it
After prescribed insulin and glucose, a patient's first glucose result is normal. Continue serial monitoring through the six-hour period illustrated by UKKA guidance, using the institution's treatment pathway. If repeat insulin-glucose treatment is needed, reassess the monitoring duration and arrange extended checks because hypoglycemia risk persists.
Common pitfall: Glucose given with insulin does not guarantee protection throughout its effect. Neither an initially normal glucose nor a falling potassium level justifies stopping glucose surveillance. Six hours is not a universal stopping point for high-risk patients or repeated treatment.
UKKA Clinical Practice Guideline: Management of Hyperkalaemia in Adults — July 2026
30.Why can potassium rebound after initial emergency treatment?
Potassium-shifting therapies temporarily move potassium into cells. As their effects diminish, extracellular potassium can rise again if excess potassium has not been removed or its cause persists. Dialysis can also be followed by redistribution from intracellular compartments. Serial potassium measurements therefore assess both initial response and recurrence. Distinguish stabilization, redistribution, and elimination when interpreting treatment progress; a single improved value does not establish that the underlying potassium problem has been resolved.
Apply it
A patient's potassium improves after insulin, but urine output remains minimal and no definitive elimination has occurred. Anticipate repeat measurements and continued planning for potassium removal rather than treating the first improvement as durable.
Common pitfall: The lowest post-treatment potassium is not necessarily the final result. Stopping reassessment after redistribution can miss recurrent hyperkalemia despite an initially successful response.
UKKA Clinical Practice Guideline: Management of Hyperkalaemia in Adults — July 2026
31.How should anticoagulation risks be assessed during CRRT?
Anticoagulation balances circuit patency against bleeding risk, existing systemic anticoagulation, and patient suitability. Regional citrate binds ionized calcium, reducing the calcium available for coagulation within the circuit. Postfilter ionized calcium assesses circuit anticoagulation; systemic ionized calcium assesses patient calcium safety. Calcium replacement compensates for calcium lost in the effluent and maintains systemic ionized calcium. Monitor acid-base status because metabolized citrate supplies bicarbonate, while impaired citrate metabolism can cause accumulation and contribute to acidosis. A rising total-to-ionized calcium ratio warns of citrate accumulation, especially with falling systemic ionized calcium or increasing calcium-replacement needs; interpret these findings with clinical status. Metabolic alkalosis from a citrate-derived alkali load can occur without accumulation.
Apply it
During citrate-anticoagulated CRRT, the postfilter ionized calcium meets the circuit target, but systemic ionized calcium falls despite increasing calcium replacement and the total-to-ionized calcium ratio rises. Promptly report suspected citrate accumulation and review acid-base results and perfusion with the team. Follow the institution's prescribed citrate and calcium adjustments; satisfactory circuit anticoagulation does not establish systemic safety.
Common pitfall: Circuit clotting can reflect access or circuit problems rather than insufficient anticoagulant. Do not use a postfilter calcium result to judge systemic calcium safety, diagnose accumulation from an acid-base disturbance alone, or equate every citrate-associated alkalosis with accumulation.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
32.Why compare delivered CRRT with the prescription?
A CRRT prescription describes intended treatment, but alarms, procedures, filter changes, and access problems can reduce actual treatment time and clearance. The delivered therapy may therefore be lower than the ordered therapy even when machine settings appear correct. Record interruptions, achieved removal, and relevant laboratory trends, then communicate clinically meaningful gaps. This distinction helps explain persistent metabolic abnormalities and prevents assuming that a displayed flow rate proves adequate treatment throughout the entire day.
Apply it
CRRT is prescribed continuously but is stopped for four hours of procedures and repeated alarms. Review actual running time and delivered treatment when potassium remains elevated instead of reporting only the programmed settings.
Common pitfall: A correct prescription cannot compensate for unrecognized downtime. Increasing settings without investigating interruptions may leave the delivery problem unresolved and complicate subsequent fluid management.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
33.When should kidney status be reassessed after AKI?
AKI survivors remain at risk for incomplete recovery, recurrent injury, and subsequent CKD. Established KDIGO guidance recommends evaluation at three months for resolution, new CKD, or worsening pre-existing CKD. Earlier review may be needed according to residual dysfunction and clinical circumstances. Discharge planning should communicate the AKI episode, latest kidney results, medication changes, and follow-up needs. A creatinine improvement before discharge is encouraging but does not replace reassessment of recovery and longer-term risk.
Apply it
A patient's creatinine improves after septic AKI but remains above baseline at discharge. Ensure the discharge plan identifies the injury, medication changes, and kidney follow-up, including reassessment for CKD around three months.
Common pitfall: Hospital discharge does not mark the end of AKI risk. Waiting for symptoms alone may miss persistent dysfunction or a new chronic kidney disease classification.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
Peritoneal Dialysis20%
34.How does peritoneal dialysis remove waste and water?
Peritoneal dialysis places solution in the abdomen so the peritoneal membrane separates dialysate from blood in nearby vessels. Waste solutes move into the solution, while the osmotic properties of the prescribed solution draw water across the membrane. Draining removes the used solution and its collected waste and water. Clearance and fluid removal depend on the prescription, membrane characteristics, and treatment completion. A bag exchange is therefore a physiological treatment, not merely fluid circulation through a catheter.
Apply it
A new patient asks why solution must remain in the abdomen before draining. Explain that the dwell provides time for exchange across the membrane and that the prescribed timing supports waste and fluid removal.
Common pitfall: Dialysate does not enter the bloodstream as an infusion. Shortening exchanges without guidance can change clearance and fluid removal even when every bag is used.
35.How is net ultrafiltration calculated for a PD exchange?
For a completed exchange, net ultrafiltration is drained volume minus instilled volume, using comparable measurements. A positive difference indicates that more fluid left than entered the abdomen, consistent with net water removal during that exchange. A negative difference requires attention to incomplete drainage, measurement error, absorption, and the overall prescription. Interpret the calculation with symptoms, weight, intake, and residual urine output. One exchange does not independently establish the patient's total daily fluid balance.
Apply it
An exchange instills 2,000 mL and drains 2,350 mL. Calculate net ultrafiltration as 350 mL, then include other exchanges, urine, and intake when assessing whether the patient's overall fluid plan is working.
Common pitfall: The entire drained volume is not net fluid removal. Comparing volumes from different exchanges or including an incomplete drain can produce a misleading result.
36.Why does PD dwell time need an individualized prescription?
Dwell time affects both solute movement and the persistence of the osmotic gradient used for fluid removal. With glucose-based solution, glucose is absorbed during the dwell, changing that gradient over time. A longer dwell therefore does not guarantee greater net fluid removal. Membrane transport characteristics and the selected solution influence the result. Evaluate drainage, weight, symptoms, and treatment records before interpreting a change, and follow the individualized prescription rather than extending or shortening dwells independently.
Apply it
A patient leaves glucose-based solution dwelling much longer than prescribed, expecting extra fluid removal. Review the exchange record and explain why progressive glucose absorption means more time does not necessarily produce more ultrafiltration.
Common pitfall: Longer is not universally better. Solute clearance and net fluid removal respond differently to time, solution choice, and the patient's peritoneal transport characteristics.
37.How do manual PD and automated PD differ?
Continuous ambulatory peritoneal dialysis uses manual exchanges distributed through the day, while automated peritoneal dialysis uses a cycler to perform prescribed exchanges, commonly overnight. Both rely on the peritoneal membrane and require safe connections, prescribed dwell patterns, and reliable completion. Their schedules create different practical demands for work, sleep, travel, and support. A cycler changes how exchanges are performed; it does not remove the need to recognize infection, drainage problems, or treatment interruptions.
Apply it
A patient considering overnight automated treatment expects no daytime responsibilities. Review the actual proposed prescription, including any daytime dwell, supply needs, and troubleshooting duties, before comparing it with a manual exchange schedule.
Common pitfall: Automated therapy does not mean unattended therapy without training. Neither schedule is inherently suitable for every patient, and both depend on consistent aseptic practice.
38.What should cloudy PD effluent trigger?
Cloudy effluent should prompt urgent assessment for PD-associated peritonitis, even when pain or fever is absent. Obtain effluent for cell count, differential, and culture according to the treatment pathway, ideally before antimicrobial therapy, without creating avoidable treatment delay. Assess symptoms, recent contamination, and clinical stability. Cloudiness has other possible causes, but waiting for every classic feature can postpone essential care. Patients should know how to contact their PD service promptly and preserve appropriate specimens.
Apply it
A home PD patient notices cloudy drainage but feels well. Direct prompt contact with the PD team and arrange specimen assessment rather than advising observation until abdominal pain or fever develops later.
Common pitfall: Absence of fever does not exclude peritonitis. Specimen collection is important, but it should not become a reason to delay urgently needed treatment.
ISPD Peritonitis Guideline Recommendations: 2022 Update on Prevention and Treatment
39.Which findings establish PD-associated peritonitis?
ISPD recommends diagnosing peritonitis when at least two of three features are present: compatible clinical features such as abdominal pain or cloudy effluent; effluent white-cell count above 100/µL after a dwell of at least two hours, with more than 50% polymorphonuclear cells; and a positive effluent culture. A culture is therefore important but not always required before diagnostic criteria are met. Interpret the cell count using dwell duration and the treatment setting.
Apply it
After a three-hour dwell, cloudy effluent contains 420 white cells/µL with 82% polymorphonuclear cells. Recognize that clinical and cellular criteria support peritonitis even while the effluent culture result is still pending.
Common pitfall: Requiring a positive culture before recognition delays care. Conversely, a cell count should not be interpreted without its differential, dwell duration, and clinical context.
ISPD Peritonitis Guideline Recommendations: 2022 Update on Prevention and Treatment
40.How should short-dwell APD effluent counts be interpreted?
Short automated PD dwells may yield an effluent white-cell count below the usual absolute threshold despite peritonitis. In this setting, the proportion of polymorphonuclear cells becomes particularly informative; more than 50% is strong evidence supporting peritonitis even if the total count is below 100/µL. Interpret that result alongside symptoms and culture assessment. The usual two-hour dwell qualification explains why mechanically applying one absolute cell-count cutoff can miss an important infection.
Apply it
An APD patient has abdominal pain and cloudy short-dwell effluent with 80 white cells/µL and 78% polymorphonuclear cells. Escalate suspected peritonitis rather than dismissing the sample because its total count is below 100.
Common pitfall: A low absolute count after a short dwell is not automatically reassuring. The polymorphonuclear proportion and clinical presentation can carry greater diagnostic weight.
ISPD Peritonitis Guideline Recommendations: 2022 Update on Prevention and Treatment
41.How should a PD connection contamination be handled?
Management depends on whether contamination could enter the peritoneal fluid pathway. Dry contamination occurs outside a closed system, such as contamination isolated from the patient by a confirmed closed clamp, without subsequent infusion through the contaminated segment. Wet contamination involves an open system or infusion after contamination. If the patient cannot confirm whether the clamp was closed, treat the event as wet contamination. ISPD suggests antibiotic prophylaxis after wet contamination; the treating PD team selects the regimen. Prophylaxis is generally unnecessary for dry contamination.
Apply it
A patient touches a connection and cannot remember whether the clamp was closed. Stop the exchange, avoid further infusion, and immediately report the event to the PD service as possible wet contamination. Describe the contact, clamp uncertainty, and whether fluid subsequently entered. The team determines connection management and antibiotic prophylaxis.
Common pitfall: Do not classify contamination as dry merely because the connection looks dry. The distinction concerns system integrity and possible microbial entry. Wiping the connection or waiting for cloudy effluent does not replace immediate reporting and appropriate management.
Peritoneal Dialysis — NIDDK · ISPD Peritonitis Guideline Recommendations: 2022 Update on Prevention and Treatment
42.What can cause poor PD drainage?
Distinguish impaired outflow with preserved inflow from obstruction in both directions. Constipation can cause outflow obstruction when a distended bowel compresses catheter drainage holes or displaces the catheter tip. Catheter migration, tissue entrapment, and adhesions are other possible outflow problems. Obstruction of both inflow and outflow suggests a tubing kink or an intraluminal fibrin plug. These patterns guide assessment but do not establish the cause by themselves. The [SAGES Peritoneal Dialysis Access Guideline Update 2023](https://www.sages.org/publications/guidelines/peritoneal-dialysis-access-guideline-update-2023/) directly supports these mechanical distinctions.
Apply it
A patient reports normal filling but poor drainage after several days without a bowel movement. Check external clamps, tubing, and position using the taught procedure; assess bowel history, retained volume, pain, and effluent appearance. Report persistent difficulty so the PD service can address constipation and investigate catheter position or obstruction.
Common pitfall: A low drain volume does not independently establish membrane ultrafiltration failure. Preserved inflow does not establish normal catheter function. Do not force irrigation or repeatedly add exchanges to overcome unexplained retained fluid; persistent dysfunction requires assessment.
43.Why should new abdominal symptoms during PD be assessed?
PD can produce sensations related to filling and abdominal fluid, but new or worsening pain should not be normalized automatically. Infection, catheter problems, leaks, and hernias can also cause symptoms. The timing of discomfort, effluent appearance, drainage, swelling, and systemic symptoms help distinguish possibilities. Prescribed warming methods may improve comfort with solution, but changing technique does not replace assessment of a new clinical problem. Promptly report persistent pain or new abdominal-wall changes.
Apply it
A patient reports a new abdominal bulge and discomfort during fills. Ask about drainage, effluent clarity, and symptom timing, and arrange PD assessment rather than simply advising the patient to tolerate the fullness.
Common pitfall: Familiar treatment-related fullness can encourage dismissal of new symptoms. Clear effluent does not exclude a mechanical complication such as a leak or hernia.
44.How can glucose-based PD affect nutrition and diabetes?
Glucose from PD solution can be absorbed into the body, contributing energy and affecting blood glucose control. This exposure should be considered when reviewing weight changes, appetite, and diabetes management. The glucose concentration also relates to the osmotic fluid-removal prescription, so patients should not change solutions solely to reduce calories or glucose readings. Coordinate assessment of dialysis effectiveness, glycemic trends, and dietary intake rather than treating these as unrelated issues.
Apply it
A patient develops higher glucose readings after a PD prescription change. Review the solution record and glucose pattern with the PD and diabetes teams, while checking whether nutrition and medication plans need coordinated adjustment.
Common pitfall: Dialysate glucose is not nutritionally invisible. Independently choosing weaker solution can compromise fluid removal, while restricting food excessively can worsen overall nutritional intake.
45.How can PD infection data guide quality improvement?
A standardized peritonitis rate relates episodes to time at risk, commonly expressed as episodes per patient-year. This allows more meaningful comparison than raw episode counts when the program population changes. Investigation should examine organisms, timing, observed technique, and system factors, then target retraining or process changes. Return demonstration can reveal practice drift that verbal reassurance misses. Evaluate subsequent outcomes using a consistent definition and denominator rather than assuming that distributing new instructions proves improvement.
Apply it
A program records six episodes during 30 patient-years of follow-up, giving 0.20 episodes per patient-year. After identifying connection errors, provide observed retraining and track subsequent rates using the same surveillance method and denominator.
Common pitfall: Fewer raw episodes may simply reflect fewer patients or shorter follow-up. A program-level rate also should not replace investigation of individual infection episodes.
ISPD Peritonitis Guideline Recommendations: 2022 Update on Prevention and Treatment · Use the Teach-Back Method: Tool 5 — AHRQ
Home Hemodialysis15%
46.What does a changed fistula thrill require?
A functioning arteriovenous fistula normally has palpable blood-flow vibration, often called a thrill. A newly absent or substantially changed thrill can signal impaired flow and requires urgent contact with the dialysis team. Assess the access according to training before treatment rather than waiting for a machine alarm. Redness, swelling, drainage, prolonged bleeding, or other changes also deserve assessment. Protecting access includes recognizing departure from the patient's usual findings, not simply confirming that an access is present.
Apply it
Before home treatment, a patient cannot feel the usual fistula thrill. The patient should promptly contact the dialysis team and follow the access plan rather than proceed with routine cannulation and see what happens.
Common pitfall: Absence of pain does not establish access patency. Delaying until the next scheduled visit can lose an opportunity to address a time-sensitive access problem.
47.How does vascular access type affect infection risk?
Hemodialysis access creates different infection risks. Central venous catheters carry the highest bloodstream-infection risk, while fistulas generally carry the lowest; grafts occupy an intermediate position. This difference reflects the presence and characteristics of foreign material and direct access to the bloodstream. Access choice still requires individualized clinical planning, but infection teaching should match the actual device. A catheter user needs particular attention to hub care, dressing protection, and prompt reporting of infection symptoms.
Apply it
A patient expects a tunneled catheter to have the same infection risk as a mature fistula. Explain the higher catheter risk and reinforce the device-specific prevention and symptom-reporting plan while access planning continues.
Common pitfall: An intact dressing does not eliminate catheter-related infection risk. Lower risk with a fistula also does not excuse poor hand hygiene or access-site care.
48.Why is catheter hub disinfection essential?
Catheter hubs provide a potential route for organisms to enter the bloodstream during connection or disconnection. CDC emphasizes disinfection of catheter hubs with an appropriate antiseptic and adherence to the required technique before access. Friction, contact time, and drying requirements follow the selected product and protocol. Hand hygiene and aseptic handling remain necessary throughout. A clean-looking hub cannot be assumed free of organisms, and a new cap does not substitute for correct disinfection.
Apply it
During observed home training, a learner plans to attach the bloodline immediately after a quick wipe of the catheter hub. Stop the connection and review the complete prescribed disinfection and drying procedure before reassessment.
Common pitfall: Visible cleanliness is not proof of microbiological safety. Rushing contact or drying time can undermine disinfection even when the learner remembers to use an antiseptic.
Best Practices for Bloodstream Infection Prevention in Dialysis Setting — CDC
49.How should clean supplies be protected during home treatment?
A prepared treatment area should keep clean supplies separate from used equipment and potentially contaminated surfaces. Hand hygiene is required at the appropriate points, including after touching items that can transfer organisms back to the access or connection system. Gloves do not eliminate this requirement. Organizing supplies before treatment reduces avoidable movement between clean and contaminated tasks. Observe the actual workflow because a learner may recite infection-prevention rules while still contaminating supplies during setup.
Apply it
A patient uses gloved hands to move a waste container and then reaches for a sterile connection. Identify the break in workflow and have the patient restore hand hygiene and clean handling before proceeding.
Common pitfall: Gloves become contaminated during use. Wearing the same pair throughout setup does not preserve asepsis when the hands move between dirty and clean tasks.
Best Practices for Bloodstream Infection Prevention in Dialysis Setting — CDC
50.How does target weight guide hemodialysis fluid removal?
Target weight helps estimate the post-treatment weight at which excess fluid has been removed without producing clinically important volume depletion. The difference between current weight and the treatment goal informs fluid planning, but food, clothing, scale variation, and true tissue-weight changes can affect interpretation. Symptoms, blood pressure, edema, breathing, and recent trends must accompany the number. A target is a clinical estimate that may need reassessment rather than a permanent instruction to remove the same volume.
Apply it
A patient's weight is above the usual target after several weeks of improved appetite and muscle gain, with no congestion. Bring the trend for reassessment rather than assuming that every extra kilogram represents removable fluid.
Common pitfall: Scale weight includes tissue as well as water. Pursuing an outdated target can cause depletion, while a rising target can also conceal untreated fluid overload.
51.Why can rapid ultrafiltration cause treatment symptoms?
Ultrafiltration removes water from the bloodstream. If removal exceeds the rate at which fluid returns from other compartments, circulating volume can fall, contributing to hypotension, dizziness, nausea, or muscle cramps. Review the removal goal, treatment duration, recent intake, and target-weight assessment when symptoms recur. Symptoms require the trained response and clinical review; they should not be dismissed as an unavoidable sign of effective dialysis. Fluid management includes both treatment delivery and the interval between sessions.
Apply it
A patient repeatedly becomes dizzy late in treatments with large fluid-removal goals. Follow the taught symptom-response plan and report the pattern so the team can reassess removal, treatment time, and target weight.
Common pitfall: Removing the planned volume is not success if perfusion becomes unsafe. Recurrent cramps should prompt assessment rather than routine acceptance or independent prescription changes.
52.Which demonstrations establish readiness for home hemodialysis?
Readiness requires observed performance of routine treatment and emergency assessment using the prescribed device. For a pressure alarm, the learner must assess the patient, identify whether pressure is high or low, and inspect the access and entire bloodline circuit. High pressure warrants checking for kinks or clots; low pressure warrants checking for loose connections, leaks, disconnection, or needle dislodgement. Identify and resolve the cause before restarting, then verify that the operating pressure is acceptable. MHRA guidance supports these assessment steps; equipment controls and restart procedures remain device specific.
Apply it
During a simulated low venous-pressure alarm after patient movement, successful performance includes checking for bleeding and instability, exposing the access and bloodlines, and inspecting connections and needle position. The learner follows the device's trained protective actions, obtains urgent help for bleeding or instability, and does not restart with an unresolved cause. After an appropriate restart, the learner checks the pressure again and stops if it remains unexpectedly low.
Common pitfall: Silencing an alarm does not correct its cause. Some machines can recenter alarm limits after restarting. Partial or complete disconnection may also fail to produce a sufficient pressure change to trigger an alarm, so direct access and circuit observation remains essential. Reassess unsuccessful demonstrations before independent treatment.
Hemodialysis — NIDDK · Use the Teach-Back Method: Tool 5 — AHRQ · Haemodialysis and haemofiltration machines: Actions to take following pressure-related alarms to avoid unintentional alteration of alarm limits DSI/2022/004 - GOV.UK
53.Why does home dialysis require an approved water system?
Water used to prepare dialysate must meet dialysis requirements. Drinking-water disinfectants, including chlorine and chloramine, require removal before dialysis use. These chemical hazards differ from microbial contamination and bacterial endotoxins, which require separate control and monitoring. Passing a chemical check does not establish microbial safety, and clear appearance establishes neither. Some prescribed home systems use prepared dialysate without a household water-treatment pathway. See [CDC dialysis-water guidance](https://www.cdc.gov/dialysis-safety/hcp/recommendations-resources/water-use-in-dialysis.html) and [CDC chlorine and chloramine guidance](https://www.cdc.gov/drinking-water/about/about-water-disinfection-with-chlorine-and-chloramine.html).
Apply it
Before treatment with a system that prepares dialysate from household water, a required disinfectant-removal check fails. Withhold treatment using that water and contact the home dialysis service for corrective action and an alternative treatment arrangement if needed. Explain that municipal drinking-water suitability does not establish suitability for dialysis.
Common pitfall: Do not substitute boiling, clear appearance, or a different patient's testing routine for the prescribed system's requirements. Chemical, microbial, and endotoxin assessments answer different safety questions. Following a water or power interruption, obtain assistance before resuming if water quality or equipment safety is uncertain.
Hemodialysis — NIDDK · Reopening Dialysis Clinics after Restoration of Power and Water | FDA
54.How should home-treatment burden be reassessed?
Home hemodialysis can offer scheduling flexibility while adding equipment, storage, monitoring, and sometimes caregiver responsibilities. Readiness can change with illness, fatigue, work demands, or loss of support. Ask directly about missed steps, shortened treatments, and caregiver strain without blame. Review findings with the team to adjust support and reassess feasibility. A previously competent patient may need retraining or additional help, and acknowledging burden can prevent unsafe workarounds from becoming routine practice.
Apply it
A caregiver reports exhaustion and the patient admits skipping preparation checks to save time. Explore the burden, reassess both people's tasks, and coordinate support and retraining before the shortcuts become an established routine.
Common pitfall: Flexibility does not remove treatment workload. Interpreting every difficulty as nonadherence can conceal practical barriers and discourage disclosure of errors or caregiver exhaustion.
Transplant10%
55.Why must immunosuppression continue when a graft works well?
The immune system can recognize a transplanted kidney as foreign even when the recipient feels well and kidney tests are stable. Immunosuppressive medicines reduce this immune response and must be taken as prescribed for as long as the functioning transplant requires them. Good results show that the overall regimen may be working; they do not demonstrate that immune protection is unnecessary. Missed doses, adverse effects, and access problems should be discussed promptly with the transplant team.
Apply it
A recipient with stable creatinine wants to stop anti-rejection medicines because the kidney has settled in. Explain the continuing immune risk and explore adverse effects or cost barriers before they lead to missed doses.
Common pitfall: Absence of symptoms is not proof of immune tolerance. Independently reducing medication can jeopardize the graft even after a long period of stable function.
56.How should infection symptoms be handled after transplantation?
Immunosuppression increases susceptibility to infection and can alter its presentation. Fever, chills, urinary symptoms, respiratory symptoms, or other new illness warrant prompt contact with the transplant team according to the recipient's instructions. Assess severity and arrange emergency help when indicated by instability. Infection and rejection require different management, so patients should not stop immunosuppression or self-treat on assumption. Early communication allows targeted evaluation while protecting both the recipient and the transplanted kidney.
Apply it
A transplant recipient taking immunosuppression develops fever and painful urination. Arrange prompt transplant-team assessment, with urgent escalation for instability, rather than suggesting several days of observation or self-directed medication changes at home.
Common pitfall: Feeling only mildly unwell does not exclude important infection during immunosuppression. Stopping anti-rejection medicines without direction creates another risk and does not establish the diagnosis.
57.Why are routine graft tests needed without symptoms?
Graft dysfunction, including rejection, may be detected through monitoring before the recipient notices symptoms. Scheduled blood and urine testing assesses kidney function and helps the team review the effects and safety of treatment. A rising creatinine warrants evaluation but does not identify rejection by itself; dehydration, infection, medication effects, and obstruction are among other possibilities. Interpret the trend and associated findings rather than using well-being as a substitute for scheduled surveillance or diagnosing from one result.
Apply it
A recipient feels well but has a new creatinine rise on scheduled testing. Notify the transplant team for evaluation and review relevant medication and illness history rather than postponing assessment until symptoms develop.
Common pitfall: Normal urine output does not exclude graft dysfunction. A creatinine rise is an investigation trigger, not proof that rejection has occurred or that immunosuppression should change.
58.What does delayed graft function mean for early care?
A transplanted kidney may not begin working adequately immediately after surgery. Some recipients need temporary dialysis while the new kidney recovers, so early dialysis does not by itself prove permanent graft failure. Continue monitoring urine output, kidney tests, fluid status, and complications while the transplant team evaluates function. The need for support and the possibility of recovery must be explained together, avoiding either premature certainty of failure or an unsupported guarantee of rapid improvement.
Apply it
A recipient requires dialysis soon after transplantation and fears the operation has failed. Explain that temporary support can be needed while function develops, while reinforcing the importance of ongoing assessment and the prescribed anti-rejection regimen.
Common pitfall: Early dialysis is not synonymous with permanent graft loss. Delayed function also should not be assumed benign without evaluation of graft perfusion and other possible causes.
59.Why must new medicines be checked with the transplant team?
Tacrolimus exposure can change substantially when interacting products are started or stopped. St John's wort induces CYP3A enzymes, increasing tacrolimus metabolism and lowering exposure, which can increase rejection risk. Conversely, CYP3A inhibitors such as clarithromycin can increase tacrolimus exposure and toxicity, including nephrotoxicity and neurotoxicity. Medication reconciliation must include prescriptions, nonprescription medicines, and supplements. The prescribing information recommends therapeutic concentration monitoring, with monitoring frequency influenced by interacting medication changes. Concentrations support assessment alongside kidney function and clinical findings; they do not replace them.
Apply it
A recipient taking tacrolimus asks about starting St John's wort. Explain the enzyme-induction mechanism and rejection risk, and obtain transplant-team review before use. If the patient has already started it, promptly report the product, dose, and timing. The team determines medication changes and prescribed tacrolimus concentration monitoring.
Common pitfall: Separating administration times does not prevent an interaction caused by enzyme induction or inhibition. Stopping an interacting product can also change tacrolimus exposure. Patients should not independently compensate by changing tacrolimus doses, and a concentration within the prescribed target does not exclude every cause of graft dysfunction.
60.How does care change after a successful transplant?
A successful transplant can replace much kidney function and reduce dialysis-related burdens, but it requires ongoing medication, monitoring, and preventive care. Follow-up addresses graft function, treatment adverse effects, infection risk, and broader health needs. Daily life may improve while anxiety, financial pressures, or difficulty maintaining routines remain. Education should translate the new plan into achievable habits and verify understanding. The transition is a change in treatment responsibilities rather than an end to kidney-related care.
Apply it
A recipient skips follow-up after returning to work because dialysis is no longer needed. Explore scheduling barriers and use teach-back to build a workable monitoring and medication plan with the transplant service.
Common pitfall: Freedom from dialysis does not remove the need for surveillance. Repeating instructions without addressing work, cost, or emotional barriers may leave the underlying problem unchanged.
Kidney Transplant — NIDDK · Use the Teach-Back Method: Tool 5 — AHRQ
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Use cause, chronicity, GFR, and albuminuria together; distinguish diagnosis, classification, and risk rather than treating them as interchangeable.
- Recognize AKI from timed changes and urine output, then prioritize dangerous electrolyte, acid-base, and fluid complications.
- Separate membrane protection, intracellular potassium shifting, and potassium elimination; pair treatment with glucose and potassium reassessment.
- Interpret PD symptoms, dwell-dependent cell counts, net ultrafiltration, and contamination events using specific discriminating cues.
- Connect home-hemodialysis access assessment, infection prevention, fluid tolerance, and demonstrated emergency competence.
- Protect transplant function through medication consistency, prompt illness reporting, and surveillance even when the recipient feels well.
- Practise teaching, medication safety, interdisciplinary care, and quality improvement across all five domains rather than studying them as isolated topics.
A practical preparation plan
1. Map experience to the official outline
Use the September 2026 specifications and linked blueprint as the full scope. Mark unfamiliar settings, especially home therapies, acute inpatient treatment, nondialysis CKD, or transplantation outside your usual practice.
2. Allocate study by domain and weakness
Start with the official 30%, 25%, 20%, 15%, and 10% content weights, then add time where your experience is limited. Keep all five domains in the plan rather than concentrating only on your current modality.
3. Explain mechanisms before memorizing actions
For each concept, state the mechanism, decisive clue, appropriate action, and boundary. Rehearse CGA classification, timed urine-output calculations, fluid accounting, PD ultrafiltration, and standardized infection-rate calculations with units.
4. Study safety as a sequence
Walk through access assessment, aseptic connection, treatment monitoring, complication recognition, escalation, and reassessment. Use return demonstration for procedures and teach-back for medication and symptom-reporting instructions.
5. Review every distractor
Complete the 20 questions before reading the explanations. For each error, identify whether the problem was an overlooked cue, an incorrect mechanism, a calculation, or confusion between modalities. Explain why each alternative is less appropriate.
6. Retest understanding across settings
Use the flashcards for spaced recall, then create a new case with changed timing, symptoms, or laboratory values. Revisit the official objectives to identify areas this selective guide has not sampled.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- CNN — Nephrology Nursing Certification Commission
- Certified Nephrology Nurse Examination (CNN): Weights for Blueprint Categories
- New Test Blueprint: Distribution of 150 Items in the Certified Nephrology Nurse Examination
- Attention All Current CDN and CNN Certificants — January 19, 2026
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
- CKD Evaluation and Management — KDIGO
- KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease
- Anemia in Chronic Kidney Disease — NIDDK
- Mineral & Bone Disorder in Chronic Kidney Disease — NIDDK
- Keeping Kidneys Safe: Smart Choices about Medicines — NIDDK
- Use the Teach-Back Method: Tool 5 — AHRQ
- Acute Kidney Injury and Acute Kidney Disease — KDIGO
- KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
- UKKA Clinical Practice Guideline: Management of Hyperkalaemia in Adults — July 2026
- ISPD Peritonitis Guideline Recommendations: 2022 Update on Prevention and Treatment
- Peritoneal Dialysis — NIDDK
- Hemodialysis — NIDDK
- Best Practices for Bloodstream Infection Prevention in Dialysis Setting — CDC
- Infections and Patients on Dialysis — CDC
- Kidney Transplant — NIDDK
- Reopening Dialysis Clinics after Restoration of Power and Water | FDA
- KITxpGL_summary.pdf
- Tacrolimus
- Haemodialysis and haemofiltration machines: Actions to take following pressure-related alarms to avoid unintentional alteration of alarm limits DSI/2022/004 - GOV.UK
- DailyMed - IBUPROFEN tablet
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.